The World Health Organization estimates that > 500 million people have been infected with COVID-19 since the beginning of the pandemic, and slightly > 6 million have died.1 As for the impact of the COVID-19 pandemic on children, the United Nations Children’s Fund (UNICEF) declared that “COVID-19 has affected children at an unprecedented scale, making it the worst crisis for children UNICEF has seen in its 75-year history”.2
Immunizing children against COVID-19 is important for their own and their caregivers’ health. COVID-19 infection in children can lead to multisystem inflammatory syndrome3 and several other long-term sequelae. Furthermore, around 16–19% of children can be asymptomatic and thus may be silent spreaders of the virus.4
A review of the literature revealed a scarcity of research on caregivers’ intention to vaccinate children against COVID-19 from the Arab world and Oman in particular.5,6 In Oman, vaccinations for adults > 18 years, started in December 2020 and was widely accepted. Oman’s Ministry of Health implemented a standardized electronic system ‘Tarassud’ as a vaccination registry, and passive vaccine adverse event surveillance and reporting were done using the same system. Vaccinations for children aged 12–18 started in August 2021 utilizing schools and the national exhibition center as sites for vaccination. The vaccination coverage for this age category is > 98%. There were no major adverse reactions reported or linked to the utilization of the COVID-19 vaccines in Oman.7
Vaccines against COVID-19 for children aged 5–11 years old have been offered in the USA and other countries since late 2021.8,9 Some countries, including Oman, an Arab country with almost five million inhabitants, have not started vaccination campaigns for this age group. Oman, however, is considering offering COVID-19 vaccines to this age group soon. Omani parents’ acceptance to vaccinate their 5–11 year-old children was unexplored.
Vaccine hesitancy is defined as a “delay in acceptance or refusal of vaccination despite availability of vaccination services”.10 Vaccine hesitancy is complex and context-specific, varying across time and countries.11 Over the past two years, studies have documented the prevalence of and reasons for COVID-19 vaccine hesitancy among adults and caregivers before and after the development of COVID-19 vaccines.12 Reasons for vaccine hesitancy include political ideology13; belief in conspiracy theories14; mistrust in government, medical authorities, and the pharmaceutical industry15; and doubts about the safety, efficacy, and side effects of vaccines.16 COVID-19 vaccine hesitancy tends to be more prevalent among some populations, such as pregnant and lactating women17 and caregivers of young children.18,19 Data from multiple surveys showed that 42–66% of parents were either hesitant about or opposed to vaccinating their 5–11 year-old children.20 Variables that predict a pediatric higher level of vaccination hesitancy include caregivers’ gender (female),20,21 pregnant women,22–26 and caregivers with a low level of education20,22,27 tend to have lower acceptance of vaccinations.
Thus, the aim of the current study was to identify factors that would influence mothers’ intentions to vaccinate their 5–11 year-old children if vaccines for children were to become available. Understanding these factors is important for the development of an evidence-based well-designed, persuasive vaccination campaign. The results of this study will assist policymakers, healthcare providers, and public health officials in designing public health strategies to encourage mothers to vaccinate their young children against COVID-19.
Methods
A cross-sectional study was conducted from 20 February to 13 March 2022 among mothers attending seven primary health centers in Muscat governorate, the capital of Oman, for medical care.
Only mothers who are Omani citizens of children aged 5–11 years old and consented to take the survey were eligible to participate in the study. A face-to-face interviewer-administered questionnaire was conducted with a convenience sample. To determine a representative sample size for mothers, we assumed that 50% of mothers are hesitant about their views (p = 0.500). A minimum of 550 participants would be needed based on the sample size formula, an interval of confidence of 99% (z value of 2.58), a margin of error of 5% (delta value of 0.05), and a participation refusal rate of 20%.
Fourteen general physicians working in primary health care were recruited and trained on the objectives of the study and data collection. A total of 954 eligible mothers were approached, and 700 completed the surveys (response rate = 73.4%). They were assured of the confidentiality of the collected information, and that their participation in the study was voluntary. The study questionnaire was written and administered in Arabic and piloted on 25 mothers. The pilot study suggested minor word changes and deletion of two items.
The study protocol was approved by the Regional Study Approval and Ethical Review Committee (MoH/CSR/22/25452) at the Directorate General of Health Services in Muscat governorate.
The survey consisted of two parts. The first part contained questions intended to gather socio-demographic data while the second part included three measures that gauged trust in doctors, vaccine hesitancy, and intention to vaccinate children.
Data were collected on the mothers’ age, household income, education level, number of children aged 5–11, employment status, and COVID-19 vaccination status as well as their spouse’s vaccination status. Education level was gauged by one item that asked participants to indicate the highest level of education they obtained. They were provided with six response options that ranged from 1 (did not attend school) to 6 (postgraduate degree). Employment status was assessed by one question with two responses: currently employed or not employed.
Regarding mothers’ and their spouses’ COVID-19 vaccination status, we asked whether they had received one dose, two doses, two doses and a booster shot, or no vaccines against COVID-19.
Trust in doctors was measured by one item that asked, “Generally speaking, to what extent do you trust your doctor?” A five-point Likert scale was used with responses ranging from 1 (do not trust at all) to 5 (always trust). Higher scores indicate greater trust in doctors.
We developed a 10-item vaccine hesitancy scale [Table 1], drawing on previous theoretical models and research on COVID-19 vaccine hesitancy.28,29 Examples of items include “COVID-19 vaccines for children are effective” and “It is important to vaccinate all children 5–11 years old against COVID-19.” All items were scored on a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). After reverse scoring two positively worded items, all items were averaged to create the vaccine hesitancy scale, with higher scores indicating higher vaccine hesitancy.
Table 1: Mean and SD for the vaccine reluctance scale items.
Children's COVID-19 vaccines are effective.*
|
2.8
|
1.1
|
The COVID-19 vaccines for children might have serious side effects.
|
2.9
|
0.8
|
The pharmaceutical companies are more interested in profit than making sure that COVID-19 vaccines for children are safe.
|
3.2
|
1.1
|
The COVID-19 vaccines for children might cause unknown long-term serious health problems.
|
3.1
|
0.9
|
The development of the COVID-19 vaccines was fast which makes them unsafe.
|
3.1
|
1.0
|
I do not trust that the COVID-19 vaccines can protect children from COVID-19 disease
|
3.1
|
1.1
|
It is important to vaccinate all children 9-11 years old against COVID-19.*
|
2.8
|
1.2
|
The COVID-19 vaccines for children might cause serious side effects more than the disease itself.
|
2.9
|
0.9
|
The COVID-19 vaccines might negatively impact the fertility of children in the future.
|
2.8
|
0.9
|
*Items are reversed coded.
A single item was used to measure mothers’ intention to vaccinate their children against COVID-19: “What is the likelihood that you would get your 5–11 year-old children vaccinated against COVID-19 if such a vaccine became available in Oman?” Response options ranged from 1 (very unlikely) to 5 (very likely). Higher scores signified greater intention to vaccinate children against COVID-19.
Statistical analyses were performed using SPSS (IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp.). A descriptive analysis was first conducted reporting frequencies and percentages of socio-demographic data and the study variables. The association between the intention to vaccinate children and each individual variable in the study was examined using bivariate and multivariable logistic regression analyses to assess determinants of higher level of intention to vaccinate children against COVID-19. The multivariable logistic regression was performed with 95% CI.
Before we conducted the logistic regression, education level was dichotomized into “high school or less” and “college degree or higher,” and vaccine hesitancy scale scores were divided into “high hesitancy and “low hesitancy” based on the mean score on the scale (M = 2.96). We also grouped intention to vaccinate children into two categories. The responses “very likely” and “likely” were labeled “intends to vaccinate” and the responses “very unlikely,” “unlikely,” and “unsure” were labeled “does not intend to vaccinate.” The dichotomizations of vaccine hesitancy and vaccination intention were done in previous studies.21,30 Age and trust in doctors were not dichotomized.
The vaccine hesitancy scale was subjected to factor analysis using principal axis factoring with the Promax rotation (k = 4) and its reliability was tested using Cronbach’s alpha.
Variables associated with the intention to vaccinate children < 0.10 were included in the multivariable logistic regression.31 In both analyses, the odds ratio (OR) values and their 95% CI were calculated. The model fit of the multivariable logistic regression analysis was assessed using the Hosmer-Lemeshow goodness-of-fit test. A p-value of < 0.05 was deemed statistically significant for all tests.
Results
As shown in Table 1, the mean age of the mothers was 37.6±5.2. Most mothers (n = 525, 75.0%) had 1–2 children, while (n = 154, 22.0%) had 3–4 children. Slightly, more than half of the children (52.1%) were boys. Most of the respondents (73.0%) had a college degree or higher and 70.8% were working full-time at the time of data collection. Slightly, more than half (53.1%) reported a monthly income of 1802 Omani riyals (equivalent to 4681 USD) or higher, which is slightly higher than the average monthly income of about 1800 riyals per month. Half of the mothers (50.1%) said they had tested positive for COVID-19, 43.0% said they had never tested positive, and 6.9% were not sure. Two-thirds (62.9%) received two doses of a COVID-19 vaccine, one-third (36.8%) had received two doses and a booster shot, and 0.3% had received only one dose. Participants, report on their spouse’s vaccination status showed that 55.2% had received two doses and 44.7% had received two doses and a booster shot. One spouse had received only one dose [Table 2].
Table 2: Characteristics of the study sample.
Age, mean ± SD, years
|
37.6 ± 5.2
|
Monthly income
|
|
≤ 4679 USD (1802 Omani Riyals)
|
233 (46.9)
|
≥ 4681 USD (1724 Omani Riyals)
|
264 (53.1)
|
Gender of children
|
|
Boys
|
486 (52.1)
|
Girls
|
447 (43.9)
|
Education
|
|
College degree or higher
|
510 (73.0)
|
High school or less
|
189 (27.0)
|
Employment status
|
|
Working
|
492 (70.8)
|
Not working
|
203 (29.2)
|
COVID-19 experience
|
|
Tested positive
|
349 (50.1)
|
Never tested positive
|
299 (43.0)
|
Not sure/do not know
|
48 (6.9)
|
Mother vaccination status
|
|
One dose
|
2 (0.3)
|
Two doses
|
429 (62.9)
|
Two doses and booster
|
251 (36.8)
|
Spouse vaccination status
|
|
One dose
|
1 (0.1)
|
Two doses
|
385 (55.2)
|
*Total percent may not sum to 100% because of missing responses.
N = 700.
Regarding mothers’ intention to vaccinate their children against COVID-19, 56.0% (n = 392) reported that they were likely or very likely to get their children vaccinated, 25.0% said they were unlikely or very unlikely to get their children vaccinated, and 19.0% (n = 133) were not sure.
Bivariate analysis showed that age, income, education level, trust in doctors, and vaccine hesitancy were related to the mothers’ intention to vaccinate their children [Table 3].
Table 3: Odds ratio (OR) and 95% CI of intent to vaccinate children 5-11 years old by intention and demographic variables.
Age
|
1.05 [1.02–1.08]
|
0.003
|
1.07 [1.02–1.12]
|
0.004
|
Income (ref: < 1800)
|
|
|
|
|
≥ 1800 OR
|
1.73 [1.20–2.49]
|
0.003
|
0.73 [0.41–1.30]
|
0.290
|
Education (ref: High school or less)
|
|
|
|
|
College degree or higher
|
0.67 [0.48–0.94]
|
0.020
|
1.35 [0.71–2.58]
|
0.360
|
Employment (ref: Not working)
|
|
|
|
|
Working
|
0.94 [0.68–1.30]
|
0.710
|
|
|
Trust in doctor physician
|
2.12 [1.71–2.62]
|
< 0.001
|
1.63 [1.18–2.25]
|
0.003
|
Vaccine hesitancy (ref: High hesitancy)
|
|
|
|
|
Hosmer–Lemeshow test, chi-square: 3.68, p-value = 0.890.
Employment status was not related to intention to vaccinate. Intention to vaccinate children was associated with older age (OR = 1.05, 95% CI: 1.02–1.08; p = 0.003), higher income (OR = 1.73, 95% CI: 1.20–2.49; p = 0.003), and a higher level of education (OR = 0.67, 95% CI: 0.48–0.94; p = 0.020). Moreover, increased odds of intention to vaccinate children were associated with trust in doctors (OR = 2.12, 95% CI: 1.71–2.62; p < 0.001) and a lower level of vaccination hesitancy (OR = 25.91, 95% CI: 16.92–39.64; p < 0.001).
In the multivariable binary logistic regression, we included all the predictors analyzed in the univariable models except for employment status [Table 3]. Intention to vaccinate children was associated with older age (OR = 1.07, 95% CI: 1.02–1.12; p = 0.004), trust in doctors (OR = 1.63, 95% CI: 1.18–2.25; p = 0.003), and low level of vaccinate hesitancy (OR = 19.23, 95% CI: 11.28–32.78; p < 0.001).
Discussion
The negative impact of COVID-19 on the well-being of children and adolescents has been documented in several studies. Vaccinating children against COVID-19 is critical for their mental and physical health and allows them to socialize with their peers. At the societal level, vaccinating younger children along with older children and adults is an effective preventive strategy for halting the spread of COVID-19. Understanding the factors that influence caregivers’ willingness to vaccinate their children is crucial considering the expanding availability of COVID-19 vaccines for children aged 5–11 years old around the world.
In this study, 44.0% (n = 308) of mothers expressed reservations about vaccinating their children. This result is similar to percentages previously reported worldwide.32 To illustrate, studies estimate that COVID-19 vaccine hesitancy among parents is 25% in Saudi Arabia,33 12% in the UAE,34 10%–30% in Western countries,25–35 and 52.5% in China.26 Furthermore, among the 22 Middle East/North African countries, the highest rate of vaccine acceptance was reported in Tunisia (92%), while the lowest rate was reported in Iraq (13%).34
The hesitation of mothers in this study to vaccinate their children could be attributed to concerns about the side effects and safety,6 efficacy of the COVID-19 vaccine, or the misconception that COVID-19 is not a serious disease. Furthermore, the mothers could be concerned about the vaccine’s long-term side effects on children, especially with widespread rumors in the community and misinformation in social media about the impact of the vaccine on women’s fertility. These concerns should be addressed in the development of COVID-19 education and awareness for vaccine campaigns geared toward caregivers.
In the present study, 56.0% (n = 392) of mothers reported that they intended to vaccinate their children between the ages of 5 and 11 against COVID-19. This is much lower than the reported rates of 65.5% in Italy, 37 80% in New Zealand,38and 91% in Brazil.24 The low rate of intention to vaccinate children in our study might be because we only studied mothers, who often tend to be more reluctant to vaccinate their children against COVID-19 than fathers.39,40
Univariable analysis showed a significant association between mothers’ older age, higher income, and higher level of education and their intention to vaccinate their children. These findings are consistent with prior published reports.18,21,41–44 Mothers with a high level of education tend to have a higher perception of the risks associated with COVID-19 for their children and are less likely to be influenced by misconceptions; as shown in some studies greater trust in doctors and a lower level of vaccine hesitancy were significant predictors of intention to vaccinate children against COVID-19. In the vaccine literature, both variables have been shown to be associated not only with the intention to vaccinate children,45,46 but with engaging in COVID-19 protective behaviors and uptake of COVID-19 vaccines.47–50
The findings of the present study suggest that public health intervention programs designed to increase caregivers’ willingness to vaccinate their young children should focus on reducing misinformation about the safety and effectiveness of COVID-19 vaccines for children. Special attention should be directed toward younger and less educated caregivers. Furthermore, healthcare workers must be equipped with effective persuasive communication skills and information required to foster positive attitudes toward the COVID-19 vaccine among caregivers.
Although our study is one of the pioneer studies in the Arab world, it has some limitations. First, while our study included a large number of participants with diverse socio-demographic backgrounds, the exclusive focus on mothers limits the generalizability of the findings. It would be important for future studies to gauge the intention of both fathers and mothers to vaccinate their children. The second limitation is related to the potential impact of participants’ wishing to preserve their social desirability due to the mode of data collection. They may have exaggerated their intention to vaccinate their children against COVID-19 because they were interviewed by healthcare providers. Additionally, because the informed consent communicated the true purpose of the study, it might be possible that mothers with a strong positive or negative opinion about COVID-19 opted to participate in the study. Another limitation is related to the type of participants. Specifically, the participants were mothers who were seeking nonurgent care for their children at health care centers. Being at a health care center might have increased some mothers’ concern about their children’s well-being, either negatively or positively. Finally, like other studies on attitudes, this study focused on mothers’ intention to vaccinate their children and not on their actual behavior.
Conclusion
More than half of the mothers in this study reported that they intended to vaccinate their children against COVID-19. Those who were older and had a higher income and level of education were more likely to say that they intended to vaccinate their children. The results of this study can be utilized to inform decision-makers, healthcare providers, and public health officials as they consider developing public health strategies to increase mothers’ intention to get their children vaccinated and their follow-through in advance of the upcoming COVID-19 vaccination campaign for children aged 5–11 years in Oman.
Disclosure
The authors declared no conflicts of interest. No funding was received for this study.
references
- 1. World Health Organization. WHO coronavirus (COVID-19) dashboard. [cited 2022 April 22]. Available from: https://covid19.who.int/.
- 2. UNICEF. Preventing a lost decade. [cited 2022 April 24]. Available from: https://www.unicef.org/media/112891/file/UNICEF%2075%20report.pdf.
- 3. Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol 2020 Nov;72(11):1791-1805.
- 4. Rubens JH, Akindele NP, Tschudy MM, Sick-Samuels AC. Acute covid-19 and multisystem inflammatory syndrome in children. BMJ 2021 Mar;372(385):n385.
- 5. Musa S, Dergaa I, Abdulmalik MA, Ammar A, Chamari K, Saad HB. BNT162b2 COVID-19 vaccine hesitancy among parents of 4023 young adolescents (12-15 years) in Qatar. Vaccines (Basel) 2021 Sep;9(9):981.
- 6. Alsuwaidi AR, Elbarazi I, Al-Hamad S, Aldhaheri R, Sheek-Hussein M, Narchi H. Vaccine hesitancy and its determinants among Arab parents: a cross-sectional survey in the United Arab Emirates. Human vaccines & Immunotherapeutics 2020;16(12):3163-3169.
- 7. Al Ghafri TS, Al Balushi L, Al Balushi Z, Al Hinai F, Al Hasani S, Anwar H, et al. Reporting at least one adverse effect post-COVID-19 vaccination from primary health care in Muscat. Cureus 2021 Aug;13(8):e17055.
- 8. Hause AM, Baggs J, Marquez P, Myers TR, Gee J, Su JR, et al. COVID-19 Vaccine safety in children aged 5-11 years - United States, November 3-December 19, 2021. Morbidity and Mortality Weekly Report 2021;70(51-52):1755.
- 9. Expósito Singh D, Olmedo Lucerón C, Limia Sánchez A, Guzmán Merino M, Carretero J. Estimación del impacto de la vacunación frente a la COVID-19 en la población infantil de 5-11 años. (Impact of vaccination against COVID-19 in children aged 5-11 years: a mathematical model.). Rev Esp Salud Publica 2022 Feb;96:e202202021.
- 10. WHO. Vaccine hesitancy. [cited 2022 April 23]. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
- 11. MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 2015 Aug;33(34):4161-4164.
- 12. Al-Amer R, Maneze D, Everett B, Montayre J, Villarosa AR, Dwekat E, et al. COVID-19 vaccination intention in the first year of the pandemic: a systematic review. J Clin Nurs 2022 Jan;31(1-2):62-86.
- 13. Albrecht D. Vaccination, politics and COVID-19 impacts. BMC Public Health 2022 Jan;22(1):96.
- 14. Moscardino U, Musso P, Inguglia C, Ceccon C, Miconi D, Rousseau C. Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy. Vaccine 2022 Apr 6;40(16):2379-2387.
- 15. Nguyen KH, Nguyen K, Geddes M, Allen JD, Corlin L. Trends in adolescent COVID-19 vaccination receipt and parental intent to vaccinate their adolescent children, United States, July to October, 2021. Ann Med 2022 Dec;54(1):733-742.
- 16. Wagner AL, Huang Z, Ren J, Laffoon M, Ji M, Pinckney LC, et al. Vaccine hesitancy and concerns about vaccine safety and effectiveness in Shanghai, China. Am J Prev Med 2021 Jan;60(1)(Suppl 1):S77-S86.
- 17. Egloff C, Couffignal C, Cordier AG, Deruelle P, Sibiude J, Anselem O, et al. Pregnant women’s perceptions of the COVID-19 vaccine: a French survey. PLoS One 2022 Feb;17(2):e0263512.
- 18. Szilagyi PG, Shah MD, Delgado JR, Thomas K, Vizueta N, Cui Y, et al. Parents’ intentions and perceptions about COVID-19 vaccination for their children: results from a national survey. Pediatrics 2021 Oct;148(4):e2021052335.
- 19. Temsah MH, Alhuzaimi AN, Aljamaan F, Bahkali F, Al-Eyadhy A, Alrabiaah A, et al. Parental attitudes and hesitancy about COVID-19 vs. routine childhood vaccinations: a national survey. Front Public Health 2021 Oct;9:752323.
- 20. Gerber JS, Offit PA. COVID-19 vaccines for children. Science 2021 Nov;374(6570):913.
- 21. Teasdale CA, Borrell LN, Kimball S, Rinke ML, Rane M, Fleary SA, et al. Plans to vaccinate children for coronavirus disease 2019: a survey of United States parents. The Journal of Pediatrics 2021;237:292-297.
- 22. Skirrow H, Barnett S, Bell S, Riaposova L, Mounier-Jack S, Kampmann B, et al. Women’s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK. BMC Pregnancy Childbirth 2022 Jan;22(1):33.
- 23. Ellithorpe ME, Aladé F, Adams RB, Nowak GJ. Looking ahead: caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model. Vaccine 2022 Mar;40(10):1404-1412.
- 24. Bagateli LE, Saeki EY, Fadda M, Agostoni C, Marchisio P, Milani GP. COVID-19 vaccine hesitancy among parents of children and adolescents living in Brazil. Vaccines (Basel) 2021 Sep;9(10):1115.
- 25. Montalti M, Rallo F, Guaraldi F, Bartoli L, Po G, Stillo M, et al. Would parents get their children vaccinated against SARS-CoV-2? Rate and predictors of vaccine hesitancy according to a survey over 5000 families from Bologna, Italy. Vaccines (Basel) 2021 Apr;9(4):366.
- 26. Zhang MX, Lin XQ, Chen Y, Tung TH, Zhu JS. Determinants of parental hesitancy to vaccinate their children against COVID-19 in China. Expert Rev Vaccines 2021 Oct;20(10):1339-1349.
- 27. Brandstetter S, Böhmer MM, Pawellek M, Seelbach-Göbel B, Melter M, Kabesch M, et al; KUNO-Kids study group. Parents’ intention to get vaccinated and to have their child vaccinated against COVID-19: cross-sectional analyses using data from the KUNO-Kids health study. Eur J Pediatr 2021 Nov;180(11):3405-3410.
- 28. Geiger M, Rees F, Lilleholt L, Santana AP, Zettler I, Wilhelm O, et al. Measuring the 7Cs of vaccination readiness. European Journal of Psychological Assessment 2022;38(4):261.
- 29. Ward JK, Alleaume C, Peretti-Watel P; COCONEL Group. The French public’s attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Soc Sci Med 2020 Nov;265:113414.
- 30. Xiang XM, Hollen C, Yang Q, Brumbach BH, Spain RI, Wooliscroft L. COVID-19 vaccination willingness among people with multiple sclerosis. Mult Scler J Exp Transl Clin 2021 May;7(2):20552173211017159.
- 31. Ranganathan P, Pramesh CS, Aggarwal R. Common pitfalls in statistical analysis: logistic regression. Perspect Clin Res 2017 Jul-Sep;8(3):148-151.
- 32. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine 2014 Apr;32(19):2150-2159.
- 33. Aldakhil H, Albedah N, Alturaiki N, Alajlan R, Abusalih H. Vaccine hesitancy towards childhood immunizations as a predictor of mothers’ intention to vaccinate their children against COVID-19 in Saudi Arabia. J Infect Public Health 2021 Oct;14(10):1497-1504.
- 34. Sallam M, Al-Sanafi M, Sallam M. A Global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review. J Multidiscip Healthc 2022 Jan;15:21-45.
- 35. Rhodes A, Hoq M, Measey MA, Danchin M. Intention to vaccinate against COVID-19 in Australia. Lancet Infect Dis 2021 May;21(5):e110.
- 36. COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis 2020 Jul;20(7):769-770.
- 37. Di Giuseppe G, Pelullo CP, Volgare AS, Napolitano F, Pavia M. Parents’ willingness to vaccinate their children with COVID-19 vaccine: results of a survey in Italy. Journal of Adolescent Health 2022;70(4):550-558.
- 38. Jeffs E, Lucas N, Walls T. CoVID-19: parent and caregiver concerns about reopening New Zealand schools. J Paediatr Child Health 2021 Mar;57(3):403-408.
- 40. Reinberg S. Poll: 1 in 4 parents won’t vaccinate their kids against COVID. 2021 [cited 2022 January 5]. Available from: https://www.webmd.com/vaccines/covid-19-vaccine/news/20210401/poll-1-in-4-parents-wont-vaccinate-their-kids-against-covid.
- 41.. Walker KK, Head KJ, Owens H, Zimet GD. A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months. Hum Vaccin Immunother 2021 Oct;17(10):3355-3364.
- 42. Caroline H. PippertKristin Lunz TrujilloDavid LazerMatthew BaumMatthew D SimonsonKatherine Ognyanova et al. The COVID States Project #68: Heightened parental concerns about COVID-19 vaccinations for children [cited 2021 December 24]. Available from https://osf.io/4u6hb/.
- 43. Al-Qerem W, Al Bawab AQ, Hammad A, Jaber T, Khdair SI, Kalloush H, et al. Parents’ attitudes, knowledge and practice towards vaccinating their children against COVID-19: a cross-sectional study. Hum Vaccin Immunother 2022 Nov;18(5):2044257.
- 44. Petrie JR, Chaturvedi N, Ford I, Brouwers MC, Greenlaw N, Tillin T, et al; REMOVAL Study Group. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2017 Aug;5(8):597-609.
- 45. Bono SA, Siau CS, Chen WS, Low WY, Faria de Moura Villela E, Pengpid S, et al. Adults’ acceptance of COVID-19 vaccine for children in selected lower- and middle-income countries. Vaccines (Basel) 2021 Dec;10(1):11.
- 46. Mant M, Aslemand A, Prine A, Jaagumägi Holland A. University students’ perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: a multi-methods study. PLoS One 2021 Aug;16(8):e0255447.
- 47. Shih S-F, Wagner AL, Masters NB, Prosser LA, Lu Y, Zikmund-Fisher BJ. Vaccine hesitancy and rejection of a vaccine for the novel coronavirus in the United States. Front Immunol 2021 Jun;12:558270.
- 48. Gopichandran V, Sakthivel K. Doctor-patient communication and trust in doctors during COVID 19 times-a cross sectional study in Chennai, India. PLoS One 2021 Jun;16(6):e0253497.
- 49. Reuben RC, Danladi MM, Saleh DA, Ejembi PE. Knowledge, attitudes and practices towards COVID-19: an epidemiological survey in North-Central Nigeria. J Community Health 2021 Jun;46(3):457-470.
- 50. Soveri A, Karlsson LC, Mäki O, Antfolk J, Waris O, Karlsson H, et al. Trait reactance and trust in doctors as predictors of vaccination behavior, vaccine attitudes, and use of complementary and alternative medicine in parents of young children. PLoS One 2020 Jul;15(7):e0236527.
- 51. Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, et al. COVID-19 vaccine hesitancy in the United States: a systematic review. Front Public Health 2021 Nov;9:770985.